STE Establishes $1.6B Revolving Credit Facility, $500M Term Loan for Xodus Medical Acquisition
· The NYC Memo
STERIS plc entered into two new credit agreements on November 4, 2026, administered by J.P. Morgan SE and JPMorgan Chase Bank, N.A. The first is a $1.6 billion revolving credit facility maturing November 4, 2031, replacing the prior October 7, 2024 agreement, with capacity for up to $800 million in incremental increases and $625 million in Alternative Currency Advances.
The second is a $500 million delayed draw term loan contingent on the closing of STERIS's pending acquisition of Xodus Medical, Inc., maturing five years after that closing date with quarterly principal amortization beginning in year two.